Higa Tomohiro
SEC CIK 2054280 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| TNYA | Tenaya Therapeutics, Inc. | SVP, Fin | 118.3K | — | $10.9K | 7 | 2025-03-10 | 2026-05-18 |
Most active insiders at TNYA, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | COLUMN GROUP III-A, LP | 10% | — | $3.54M |
| 2 | TCG Opportunity III GP, LLC | 10% | — | $2.37M |
| 3 | Ali Faraz | CEO, Dir | — | $32.1K |
| 4 | Tingley Whittemore | Chief Medical Off | — | $14.9K |
| 5 | Higa Tomohiro | SVP, Fin | — | $5,216 |
Transactions 7
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-05-19 19:06 | 2026-05-18 | TNYA | Tenaya Therapeutics, Inc. | Higa Tomohiro | SVP, Fin | S - Sale | $0.7932 | -1,485 | 118.3K | -1% | -$1,178 | |
| M | 2026-02-17 | 2026-02-17 | TNYA | Tenaya Therapeutics, Inc. | Higa Tomohiro | SVP, Fin | S - Sale | $0.64 | -3,469 | 122.6K | -3% | -$2,220 |
| D | 2026-02-05 | 2026-02-03 | TNYA | Tenaya Therapeutics, Inc. | Higa Tomohiro | SVP, Fin | A - Grant | $0.00 | +29.2K | 123.2K | +31% | $0 |
| 2025-11-17 | 2025-11-17 | TNYA | Tenaya Therapeutics, Inc. | Higa Tomohiro | SVP, Fin | S - Sale | $1.33 | -1,367 | 94.0K | -1% | -$1,818 | |
| M | 2025-08-18 | 2025-08-18 | TNYA | Tenaya Therapeutics, Inc. | Higa Tomohiro | SVP, Fin | S - Sale | $1.25 | -2,962 | 97.8K | -3% | -$3,702 |
| 2025-05-16 | 2025-05-16 | TNYA | Tenaya Therapeutics, Inc. | Higa Tomohiro | SVP, Fin | S - Sale | $0.44 | -1,390 | 98.3K | -1% | -$611.60 | |
| M | 2025-03-10 | 2025-03-10 | TNYA | Tenaya Therapeutics, Inc. | Higa Tomohiro | SVP, Fin | S - Sale | $0.54 | -2,482 | 100.5K | -2% | -$1,340 |
Purchase Sale Sale after option exercise All abbreviations